Community Bank, N.A. Fate Therapeutics Inc Transaction History

Community Bank, N.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$11.48 - $16.98 $17,220 - $25,470	-1,500 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$6.3 - $13.77 $18,900 - $41,310	-3,000 Reduced 66.67%	1,500 $15,000
Q4 2017 Feb 06, 2018	SELL	$3.94 - $6.64 $15,760 - $26,560	-4,000 Reduced 47.06%	4,500 $27,000
Q3 2017 Oct 30, 2017	BUY	$2.6 - $4.31 $22,100 - $36,635	8,500	8,500 $34,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $235M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Community Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Community Bank, N.A. with notifications on news.